|
1
|
González-Burgos E, Fernandez-Moriano C and
Gómez-Serranillos MP: Potential neuroprotective activity of Ginseng
in Parkinson's disease: A review. J Neuroimmune Pharmacol.
10:14–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rektor I, Goldemund D, Bednarik P,
Bednařík P, Sheardová K, Michálková Z, Telecká S, Dufek M and
Rektorová I: Impairment of brain vessels may contribute to
mortality in patients with Parkinson's disease. Mov Disord.
27:1169–1172. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fuxe K, Marcellino D, Genedani S and
Agnati L: Adenosine A(2A) receptors, dopamine D(2) receptors and
their interactions in Parkinson's disease. Mov Disord.
22:1990–2017. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tapias V, Cannon JR and Greenamyre JT:
Pomegranate juice exacerbates oxidative stress and nigrostriatal
degeneration in Parkinson's disease. Neurobiol Aging. 35:1162–1176.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Prigione A, Isaias IU, Galbussera A,
Brighina L, Begni B, Andreoni S, Pezzoli G, Antonini A and
Ferrarese C: Increased oxidative stress in lymphocytes from
untreated Parkinson's disease patients. Parkinsonism Relat Disord.
15:327–328. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tassorelli C, Furnari A, Buscone S,
Alfonsi E, Pacchetti C, Zangaglia R, Pichiecchio A, Bastianello S,
Lozza A, Allena M, et al: Pisa syndrome in Parkinson's disease:
Clinical, electromyographic, and radiological characterization. Mov
Disord. 27:227–235. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Omobowale TO, Oyagbemi AA, Oyewunmi OA and
Adejumobi OA: Chemopreventive effect of methanolic extract of
Azadirachta indica on experimental Trypanosoma brucei
induced oxidative stress in dogs. Pharmacognosy Res. 7:249–258.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dkhil MA, Al-Quraishy S, Moneim Abdel AE
and Delic D: Protective effect of Azadirachta indica extract
against Eimeria papillata-induced coccidiosis. Parasitol Res.
112:101–106. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kohl Z, Ben Abdallah N, Vogelgsang J,
Tischer L, Deusser J, Amato D, Anderson S, Müller CP, Riess O,
Masliah E, et al: Severely impaired hippocampal neurogenesis
associates with an early serotonergic deficit in a BAC α-synuclein
transgenic rat model of Parkinson's disease. Neurobiol Dis.
85:206–217. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kumar R, Hauser RA, Mostillo J, Dronamraju
N, Graf A, Merschhemke M and Kenney C: Mavoglurant (AFQ056) in
combination with increased levodopa dosages in Parkinson's disease
patients. Int J Neurosci. 126:20–24. 2013. View Article : Google Scholar
|
|
11
|
Abdenour B and Charles R: Innovative
anthocyanins formulation protects neuronal-like cells against
oxidative stress-induced damage: Pharmacotherapeutic application
for Alzheimer's disease. Free Radic Biol Med. 75 Suppl 1:S452014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu J, Wu L, Jiang T, Wang Y, Zhao H, Gao
Q, Pan Y, Tian Y and Zhang Y: Angiotensin AT2 receptor stimulation
inhibits activation of NADPH oxidase and ameliorates oxidative
stress in rotenone model of Parkinson's disease in CATHa cells.
Neurotoxicol Teratol. 47:16–24. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Steultjens MP, Stolwijk-Swüste J, Roorda
LD, Dallmeijer AJ, van Dijk GM, Post B and Dekker J: CARPA Study
Group: WOMAC-pf as a measure of physical function in patients with
Parkinson's disease and late-onset sequels of poliomyelitis:
Unidimensionality and item behaviour. Disabil Rehabil.
34:1423–1430. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Antonini A and Tinazzi M: Targeting pain
in Parkinson's disease. Lancet Neurol. 14:1144–1145. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Soares DG, Godin AM, Menezes RR, Nogueira
RD, Brito AM, Melo IS, Coura GM, Souza DG, Amaral FA, Paulino TP,
et al: Anti-inflammatory and antinociceptive activities of
azadirachtin in mice. Planta Med. 80:630–636. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu XL, Wang P, Liu YH and Xue YX: Effects
of poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide on
blood-brain barrier and dopaminergic neurons of rats with
lipopolysaccharide-induced Parkinson's disease. J Mol Neurosci.
53:1–9. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rohn TT and Catlin LW: Immunolocalization
of influenza A virus and markers of inflammation in the human
Parkinson's disease brain. PLoS One. 6:e204952011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huerta C, Sánchez-Ferrero E, Coto E,
Blázquez M, Ribacoba R, Guisasola LM, Salvador C and Alvarez V: No
association between Parkinson's disease and three polymorphisms in
the eNOS, nNOS, and iNOS genes. Neurosci Lett. 413:202–205. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pontone GM, Palanci J, Williams JR and
Bassett SS: Screening for DSM-IV-TR cognitive disorder NOS in
Parkinson's disease using the Mattis Dementia Rating Scale. Int J
Geriatr Psychiatry. 28:364–371. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim WH, Song HO, Jin CM, Hur JM, Lee HS,
Jin HY, Kim SY and Park H: The methanol extract of Azadirachta
indica A. juss leaf protects mice against lethal endotoxemia
and sepsis. Biomol Ther (Seoul). 20:96–103. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu L, Zhu B, Yang L, Zhao X, Jiang H and
Ma F: RelB regulates Bcl-xl expression and the irradiation-induced
apoptosis of murine prostate cancer cells. Biomed Rep. 2:354–358.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shrivastava P, Vaibhav K, Tabassum R, Khan
A, Ishrat T, Khan MM, Ahmad A and Islam F, Safhi MM and Islam F:
Anti-apoptotic and anti-inflammatory effect of Piperine on 6-OHDA
induced Parkinson's rat model. J Nutr Biochem. 24:680–687. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yasuda T, Hayakawa H, Nihira T, Ren YR,
Nakata Y, Nagai M, Hattori N, Miyake K, Takada M, Shimada T, et al:
Parkin-mediated protection of dopaminergic neurons in a chronic
MPTP-minipump mouse model of Parkinson disease. J Neuropathol Exp
Neurol. 70:686–697. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Manosroi A, Kitdamrongtham W, Ishii K,
Shinozaki T, Tachi Y, Takagi M, Ebina K, Zhang J, Manosroi J,
Akihisa R and Akihisa T: Limonoids from Azadirachta indica
var. siamensis extracts and their cytotoxic and
melanogenesis-inhibitory activities. Chem Biodivers. 11:505–531.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Witt SN and Flower TR: Alpha-Synuclein,
oxidative stress and apoptosis from the perspective of a yeast
model of Parkinson's disease. FEMS Yeast Res. 6:1107–1116. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bayir H, Kapralov AA, Jiang J, Huang Z,
Tyurina YY, Tyurin VA, Zhao Q, Belikova NA, Vlasova II, Maeda A, et
al: Peroxidase mechanism of lipid-dependent cross-linking of
synuclein with cytochrome C: Protection against apoptosis versus
delayed oxidative stress in Parkinson disease. J Biol Chem.
284:15951–15969. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Itoh K, Weis S, Mehraein P and
Müller-Höcker J: Defects of cytochrome c oxidase in the substantia
nigra of Parkinson's disease: And immunohistochemical and
morphometric study. Mov Disord. 12:9–16. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Manikandan P, Letchoumy PV, Gopalakrishnan
M and Nagini S: Evaluation of Azadirachta indica leaf
fractions for in vitro antioxidant potential and in vivo modulation
of biomarkers of chemoprevention in the hamster buccal pouch
carcinogenesis model. Food Chem Toxicol. 46:2332–2343. 2008.
View Article : Google Scholar : PubMed/NCBI
|
